Cipla Overtakes GSK to Become Top Indian Pharma Company (India)

So far in 2007, Cipla has emerged ahead of its competitors to become the top pharmaceutical company in the Indian domestic market with a share of 5.17 percent. Its closest competition is GlaxoSmithKline at 4.89 percent. Local leaders Ranbaxy, Nicholas Piramal, and Zydus Cadila followed up in the third, fourth, and fifth positions respectively. When international sales were taken into account, it was Ranbaxy that came out on top with the highest overall revenues of any Indian pharmaceutical manufacturer. Ranbaxy took the spot from Dr. Reddy's Laboratories, which held the lead position up until two months ago. (Click here for more